Rigetti Computing Tripled Its Revenue Last Quarter. Has It Become a Safer Stock to Buy?

Rigetti reported Q1 2026 revenue of $4.4 million, up from $1.5 million a year earlier, but operating expenses remained far higher at about $27.4 million combined SG&A and R&D, leaving an operating loss of just under $26 million. The $33 million reported profit was driven by a roughly $54 million revaluation of derivative warrant liabilities, making the earnings quality look weak. The article argues quantum computing remains very early-stage, with a $1.4 billion global market in 2024 projected to reach only $4.2 billion by 2030, and cautions that Rigetti's >$5 billion market cap looks expensive.

Analysis

Rigetti remains a classic “story stock with real but non-linear traction,” and the second-order issue is dilution risk, not just revenue volatility. When revenue is this small relative to fixed R&D and SG&A, every incremental contract matters less than the financing path needed to bridge the gap to meaningful scale; the market is effectively underwriting multiple future capital raises or equity-linked compensation overhang. That tends to cap upside even when headline growth prints well, because the marginal buyer has to price in per-share economics, not just top-line growth.

The key competitive dynamic is that quantum computing is moving from scientific credibility to ecosystem control: hardware, error correction, and developer tooling will likely converge into a winner-take-most platform, but the timeline is long enough that adjacent incumbents can absorb the innovation. That favors large balance-sheet players and cloud/platform integrators more than standalone pure plays. In that framework, RGTI is more likely to be an acquisition option or strategic partnership vehicle than a standalone compounding machine in the near term.

The market is also likely over-reading the “profit” headline. One-time fair-value adjustments can create optical earnings beats that do not improve liquidity or unit economics, so the real catalyst is not EPS but backlog conversion and repeatable booking cadence over the next 2-4 quarters. If that cadence fails to accelerate, the stock can rerate sharply lower as the market shifts from TAM optionality to cash-burn scrutiny.

Contrarian view: the consensus bearishness may be directionally right on valuation but too confident on timing. In a small-float, narrative-driven name, a single credible government, defense, or hyperscaler contract can reprice the stock far more than fundamentals would justify, so short exposure carries event risk. The better framing is that RGTI is not a business model short so much as a valuation and financing short with intermittent squeeze risk.

Key Decisions for Investors

• Short RGTI on strength into any post-earnings or headline-driven pop; use a 1-3 month horizon and size modestly because upside squeezes from strategic contract news can be violent.
• For a cleaner relative-value expression, pair long NVDA / short RGTI over 3-6 months: NVDA monetizes AI compute demand immediately, while RGTI monetizes optionality with financing risk; the spread should widen if capital markets get more selective.
• Avoid chasing RGTI as a standalone long until there is evidence of 2-3 consecutive quarters of repeatable bookings and improving cash conversion; otherwise the risk/reward is dominated by dilution rather than operating leverage.
• If traders want convex upside, consider a limited-risk call spread in RGTI only around a known catalyst window; otherwise implied volatility is likely too rich versus the probability of durable fundamental inflection.